BORTEZOMIB 2.5 mg/1 (Bortezomib INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 2.5 mg/1

Bortezomib 2.5 mg/1 is a lyophilized powder for solution, used for intravenous or subcutaneous administration. It belongs to a class of medications known as proteasome inhibitors, often explored for its potential in managing certain medical conditions.

Strength

2.5 mg/1

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1703-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in

Manufacturer / TM Owner

Hospira, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bortezomib is primarily used as a proteasome inhibitor, which may help in the management of specific medical conditions. It is often considered for its role in targeted therapy, particularly in scenarios where conventional treatments may be less effective. The exact uses of bortezomib can vary, and it is essential to consult healthcare professionals for personalized advice.

Side Effects

Common effects of bortezomib may include fatigue, nausea, and peripheral neuropathy. Some individuals might experience gastrointestinal issues or changes in blood cell counts. The specific effects can vary widely among users, and it is important to monitor any unusual symptoms closely.

Precautions & Warnings

Bortezomib should be handled with care, ensuring proper storage and preparation. It is crucial to follow the guidelines provided by healthcare professionals regarding administration and safety. Individuals with certain pre-existing conditions or allergies should exercise caution and consult their healthcare provider before use.

Avoid Interactions

Bortezomib may interact with other medications, including those that affect the liver or immune system. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements might also influence the effects of bortezomib, so it is advisable to discuss these with a healthcare professional.

References

Frequently Asked Questions

Bortezomib is used as a proteasome inhibitor, often explored for its potential in managing certain medical conditions. It is typically administered intravenously or subcutaneously.

Bortezomib is available as a lyophilized powder for solution, which can be administered either intravenously or subcutaneously. The specific method of administration should be determined by a healthcare professional.

Common side effects of bortezomib may include fatigue, nausea, and peripheral neuropathy. Some individuals might also experience gastrointestinal issues or changes in blood cell counts.

Bortezomib may interact with other medications, particularly those that affect the liver or immune system. It is important to consult a healthcare provider before combining bortezomib with other treatments.

Bortezomib should be stored according to the manufacturer's guidelines, typically in a cool, dry place away from direct sunlight. Proper storage is essential to maintain the medication's effectiveness.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.